Vnitr Lek 2011, 57(12):1025-1028
Keratin fragments as a serological indicator in patients with a liver disease
- 1 Interní klinika Lékařské fakulty Ostravské univerzity a FN Ostrava, přednosta doc. MUDr. Arnošt Martínek, CSc.
- 2 Interní gastroenterologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Aleš Hep, CSc.
- 3 Histologická laboratoř Ústí nad Orlicí, přednosta primář MUDr. Jan Nožička, Ph.D.
- 4 Oddělení klinické biochemie FN Brno, pracoviště Bohunice, přednosta doc. MUDr. Milan Dastych, CSc., MBA
- 5 Katedra biologie a ekologie Přírodovědecké fakulty Ostravské univerzity v Ostravě, vedoucí katedry Mgr. Pavel Drozd, Ph.D.
Introduction:
Determination of M30 antigen appears to be a sensitive method for evaluation of hepatocyte apoptosis. The aim of the present project was to implement this technique, compare M30 values in patients with a liver disease and healthy controls and to identify potential relationships between M30 values and other parameters.
Methods:
M30 antigen was assessed in 25 patients with a liver disease and 30 healthy controls. These results were compared between patients with a liver disease and the controls and correlated to a range of clinical and laboratory values, including tissue polypeptide-specific antigen (TPS), in patients with a liver disease.
Results:
We found significant differences in M30 values between controls and patients with a liver disease. The only significant correlations were the correlation between M30 and ALT, highly significant correlation between M30 and AST and highly significant correlation between M30 and TPS.
Conclusion:
The M30 antigen is a sensitive indicator of liver damage. Considering the highly significant correlation with TPS, it can be assumed that in some liver diseases, TPS could serve as a clinically useful indicator of apoptosis.
Keywords: liver disease; M30 antigen; tissue polypeptide-specific antigen (TPS); keratin fragments; hepatocyte apoptosis
Received: October 10, 2011; Published: December 1, 2011 Show citation
References
- R Development Core Team (2011). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna: Austria 2011. www.R-project.org.
- Hůlek P, Dresslerová I. Steatóza a steatohepatitida u diabetika. Vnitř Lék 2011; 57: 364-367.
Go to PubMed...
- Brůha R. Nealkoholová steatóza a steatohepatitida. Vnitř Lék 2010; 56: 173-175.
Go to PubMed...
- Naveau S, Gaudé G, Asnacios A et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009; 49: 97-105.
Go to original source...
Go to PubMed...
- Tajmer P. Fibróza jater. In: Špičák J (ed.). Novinky v gastroenterologii a hepatologii. 1. vyd. Praha: Grada 2008: 35-46.
- Moll R, Franke WW, Schiller DL et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
Go to original source...
Go to PubMed...
- Fuchs E, Tyner AL, Guidice G et al. The human keratin genes and their differential expression. In: Sawyer RH (ed.). The Molecular and Developmental Biology of Keratins. New York: Academic Press 1987: 5-34.
Go to original source...
- Sundström BE, D'Amico Y, Brundell J. Development of a new Profiligen TPA IRMA assay using monoclonal anti-cytokeratin antibodies. Int J Biol Markers 1995; 10: 166-173.
Go to original source...
- Ueno T, Toi M, Linder S. Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomed Pharmacother 2005; 59 (Suppl 2): S359-S362.
Go to original source...
Go to PubMed...
- Feldstein AE, Wieckowska A, Lopez AR et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009; 50: 1072-1078.
Go to original source...
Go to PubMed...
- Yilmaz Y, Dolar E, Ulukaya E et al. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007; 13: 837-844.
Go to original source...
Go to PubMed...
- Younossi ZM, Jarrar M, Nugent C et al. A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH). Obes Surg 2008; 11: 1430-1437.
Go to original source...
Go to PubMed...
- Zetterberg A, Skern T, Schoberl E et al. Molecular characterization of TPS (Abstract). 22nd Meeting. Groningen: ISOBM 1994: 354.
- Bremer K, Eklund G, Björklund B. Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer. Anticancer Res 1996; 16: 905-909.
- Glimelius B, Hoffman K, Einarsson R et al. Monitoring palliative chemotherapy in advanced gastrointestinal cancer using tissue polypeptide specific antigen (TPS) measurements. Acta Oncol 1996; 35: 141-148.
Go to original source...
Go to PubMed...
- Klečka J, Pikner R, Toufarová P et al. Cytpkeratiny TPA, TPS, CYFRA 21-1 a UBC v séru a moči jako možné nádorové markery karcinomu močového měchýře. Ces Urol 2001; 1: 32-36.
- http://www.cskb.cz/res/file/doporuceni/TM/TM_tab3.pdf.
- Gonzalez-Quintela A, Abdulkader I, Campos J et al. Serum Levels of Keratin-18 Fragments (Tissue Polypeptide-Specific Antigen TPS) Are Correlated with Hepatocyte Apoptosis in Alcoholic Hepatitis. Dig Dis Sci 2009; 54: 648-653.
Go to original source...
Go to PubMed...
- Gonzalez-Quintela A, Abdulkader I, Otero E et al. Relationship between serum concentrations of keratin-18 and apoptosis in chronic hepatitis C. Clin Chem Lab Med 2010; 48: 897-899.
Go to original source...
Go to PubMed...